Porcine PD-L1: cloning, characterization, and implications during xenotransplantation

被引:24
|
作者
Jeon, Dae-Hyun
Oh, Keunhee
Oh, Byoung C.
Nam, Dong H.
Kim, Chi H.
Park, Hyung-Bae
Cho, Jaejin
Lee, Jeong R.
Lee, Dong-Sup
Lee, Gene
机构
[1] Seoul Natl Univ, Lab Mol Genet & Stem Cell Differentiat, Seoul 110799, South Korea
[2] Seoul Natl Univ, Canc Res Inst, Lab Immunol, Seoul 110799, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea
关键词
cell proliferation; human PD-1; human T cells; porcine PD-L1; xenotransplantation;
D O I
10.1111/j.1399-3089.2007.00403.x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Effective intervention achieved by manipulating cell-mediated xenogeneic immune responses would critically increase the clinical feasibility of xenotransplantation as immediate hyperacute rejections become controllable through genetic modulations of donor organs. Endogenous negative regulatory signals like the programmed death 1 (PD-1)-programmed death ligand 1 (PD-L1) system are candidate targets for the control of cell-mediated xenogeneic immune response. Methods: A porcine PD-L1 molecule was cloned using RACE (rapid amplification of cDNA ends) technology based on the human PD-L1 sequence. The functional effects of cloned porcine PD-L1 were tested on human CD4(+) T cell activation using porcine PD-L1-transfected bystander cells. Cellular proliferation was monitored by [H-3] thymidine incorporation, and human T cell apoptosis was measured by flow cytometry. Results: Porcine PD-L1 (GenBank accession number AY837780) was found to have 73.8% sequence homology with human PD-L1 and to contain two immunoglobulin domains in its extracellular region. Moreover, porcine PD-L1 expressed on Chinese hamster ovary (CHO) cells inhibited human CD4(+) T cell proliferation stimulated with anti-CD3 only or anti-CD3 plus anti-CD28. Percentages of apoptotic activated human T cells increased by over 30% in the presence of porcine PD-L1/CHO cells, and the addition of recombinant human PD-1-Fc fusion proteins during human T cell activation reversed the inhibitory effects of porcine PD-L1. Conclusions: Cloned porcine PD-L1 showed high sequence homology with human PD-L1 and a similar molecular structure. Moreover, porcine PD-L1 inhibited human CD4(+) T cell activation in human PD-1-dependent manner, and this involved activated T cell apoptosis. The authors suggest that PD-1-PD-L1 might play an important endogenous immune regulatory role during xenogeneic transplantation, and that the effective application of this system would improve transplanted xenogeneic organ survival.
引用
收藏
页码:236 / 242
页数:7
相关论文
共 50 条
  • [1] PD-L1 Expression in Mucosal Malignant Melanoma: Implications for PD-1/PD-L1 Blockade Therapy
    Lilo, Mohammed
    Berry, Sneha
    Xu, Haiying
    Ogurtsova, Aleksandra
    Lipson, Evan
    Taube, Janis
    LABORATORY INVESTIGATION, 2015, 95 : 123A - 123A
  • [2] PD-L1 Expression in Mucosal Malignant Melanoma: Implications for PD-1/PD-L1 Blockade Therapy
    Lilo, Mohammed
    Berry, Sneha
    Xu, Haiying
    Ogurtsova, Aleksandra
    Lipson, Evan
    Taube, Janis
    MODERN PATHOLOGY, 2015, 28 : 123A - 123A
  • [3] Rise of PD-L1 expression during metastasis of colorectal cancer: Implications for immunotherapy
    Wang, Huan Bin
    Yao, Han
    Li, Chu Shu
    Liang, Lun Xi
    Zhang, Yao
    Chen, Ying Xuan
    Fang, Jing-Yuan
    Xu, Jie
    JOURNAL OF DIGESTIVE DISEASES, 2017, 18 (10) : 574 - 581
  • [4] PD-L1 and PD-1 in immune regulation and their implications in blood cancers
    Aghbash, Parisa Shiri
    Mehdizadeh, Faezeh
    Pourbeiragh, Ghazal
    Yazdani, Yalda
    Baghi, Hossein Bannazadeh
    Sales, Abolfazl Jafari
    Pashazadeh, Mehrdad
    Kangari, Parisa
    ADVANCES IN CANCER BIOLOGY-METASTASIS, 2024, 11
  • [5] PD-L1
    Kythreotou, Anthousa
    Siddique, Abdul
    Mauri, Francesco A.
    Bower, Mark
    Pinato, David J.
    JOURNAL OF CLINICAL PATHOLOGY, 2018, 71 (03) : 189 - 194
  • [6] A comparative study of PD-L1 diagnostic assays and the classification of patients as PD-L1 positive and PD-L1 negative
    Ratcliffe, Marianne J.
    Sharpe, Alan
    Midha, Anita
    Barker, Craig
    Scorer, Paul
    Walker, Jill
    CANCER RESEARCH, 2016, 76
  • [7] Clinical Implications of Exosomal PD-L1 in Cancer Immunotherapy
    Ayala-Mar, Sergio
    Donoso-Quezada, Javier
    Gonzalez-Valdez, Jose
    JOURNAL OF IMMUNOLOGY RESEARCH, 2021, 2021
  • [8] PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
    Monneur, Audrey
    Goncalves, Anthony
    Bertucci, Francois
    BULLETIN DU CANCER, 2018, 105 (03) : 261 - 272
  • [9] Prognostic implications of PD-L1 expression in patients with angiosarcoma
    Lee, Jii Bum
    Ahn, Beung-Chul
    Kim, Seung Hyun
    Lee, Young Han
    Han, Jung Woo
    Jeon, Min Kyung
    Kim, Soo Hee
    Kim, Hyo Song
    FUTURE SCIENCE OA, 2021, 7 (05):
  • [10] STRUCTURAL CHARACTERIZATION OF LINEAR ALIPHATIC AMINE-LINKED TRIARYL INHIBITORS OF PD-1/PD-L1 WITH PD-L1 DIMER
    Urban, V.
    Veresov, V.
    DuBuske, L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S61 - S62